MKI67 and breast carcinoma: We have recently reported [6] on methodology to validate and calibrate DIA for Ki67 IHC in breast cancer tissue based on reference data obtained by stereology grid count performed on the same images: comparison of the DIA results to the reference data enabled "knowledge-based" fine-tuning of the DIA settings to achieve better accuracy.